» Authors » Julien Fayada

Julien Fayada

Explore the profile of Julien Fayada including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 157
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bontoux C, Hofman V, Chamorey E, Schiappa R, Lassalle S, Long-Mira E, et al.
Am J Surg Pathol . 2024 Jul; 48(9):1072-1081. PMID: 38980727
Emerging therapies for non-small cell lung cancer targeting c-Met overexpression have recently demonstrated promising results. However, the evaluation of c-Met expression can be challenging. We aimed to study the inter...
2.
Lamas N, Lassalle S, Martel A, Nahon-Esteve S, Macocco A, Zahaf K, et al.
Pathology . 2023 Oct; 55(7):929-944. PMID: 37863710
Uveal melanoma (UM) is the most common intraocular tumour in adults, with dismal prognosis once metastases develop, since therapeutic options for the metastatic disease are ineffective. Over the past decade,...
3.
Martel A, Mograbi B, Romeo B, Gastaud L, Lalvee S, Zahaf K, et al.
Int J Mol Sci . 2023 Jul; 24(13). PMID: 37446253
Liquid biopsy and circulating tumor cell (CTC) screening has gained interest over the last two decades for detecting almost all solid malignancies. To date, the major limitation in terms of...
4.
Martel A, Gastaud L, Bonnetaud C, Nahon-Esteve S, Washetine K, Bordone O, et al.
Cancers (Basel) . 2023 May; 15(8). PMID: 37190299
Ophthalmic malignancies include various rare neoplasms involving the conjunctiva, the uvea, or the periocular area. These tumors are characterized by their scarcity as well as their histological, and sometimes genetic,...
5.
Ilie M, Benzaquen J, Hofman V, Long-Mira E, Lassalle S, Boutros J, et al.
Int J Mol Sci . 2023 Feb; 24(4). PMID: 36834888
As new SARS-CoV-2 variants emerge, there is an urgent need to increase the efficiency and availability of viral genome sequencing, notably to detect the lineage in samples with a low...
6.
Khatir W, Humbert O, Benzaquen J, Bontoux C, Neels J, Berland L, et al.
Clin Transl Med . 2022 Aug; 12(8):e1018. PMID: 35994416
No abstract available.
7.
Ilie M, Benzaquen J, Tourniaire P, Heeke S, Ayache N, Delingette H, et al.
Cancers (Basel) . 2022 Apr; 14(7). PMID: 35406511
The histological distinction of lung neuroendocrine carcinoma, including small cell lung carcinoma (SCLC), large cell neuroendocrine carcinoma (LCNEC) and atypical carcinoid (AC), can be challenging in some cases, while bearing...
8.
Hofman P, Bordone O, Chamorey E, Benzaquen J, Schiappa R, Lespinet-Fabre V, et al.
Front Med (Lausanne) . 2022 Jan; 8:730577. PMID: 35087842
Aside from the reverse transcription-PCR tests for the diagnosis of the COVID-19 in routine clinical care and population-scale screening, there is an urgent need to increase the number and the...
9.
Boutros J, Benzaquen J, Marquette C, Ilie M, Labaky M, Benchetrit D, et al.
ERJ Open Res . 2021 Dec; 7(4). PMID: 34877351
Background: The current diagnostic standard for coronavirus disease 2019 (COVID-19) is reverse transcriptase-polymerase chain reaction (RT-PCR) testing with nasopharyngeal (NP) swabs. The invasiveness and need for trained personnel make the...
10.
Massa F, Cremoni M, Gerard A, Grabsi H, Rogier L, Blois M, et al.
EBioMedicine . 2021 Nov; 73:103679. PMID: 34763205
Background: The immunogenicity of a two-dose mRNA COVID-19 vaccine regimen is low in kidney transplant (KT) recipients. Here, we provide a thorough assessment of the immunogenicity of a three-dose COVID-19...